Skip to content

Schneider Magnum Peripheral Recanal Guidewire

by Schneider Intl., Ltd.

510(k) K912156

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK912156 Date6 Sep 1991ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DQX
Device Class
Class II
Regulation
21 CFR Part 870.1330
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Schneider Magnum Peripheral Recanal Guidewire is a Guidewire designed for peripheral vascular recanalization procedures. It is intended for use in recanalizing occluded or stenotic peripheral arteries, facilitating the restoration of blood flow through obstructed vessels.

This device is supplied as a single-use, non-sterile guidewire and is classified under product code DQX as a Wire, Guide, Catheter. It was granted FDA 510(k) clearance under the Traditional review pathway, with a decision date of September 6, 1991. No additional sterility or MRI safety specifications are noted in the regulatory submission.

Other devices from Schneider Intl., Ltd.

See all devices from Schneider Intl., Ltd. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical purpose of the Schneider Magnum Peripheral Recanal Guidewire, and how does it differ from standard guidewires?

    The Schneider Magnum Peripheral Recanal Guidewire is specifically designed for peripheral vascular recanalization, meaning it is used to open occluded or narrowed arteries in the legs, arms, or other peripheral blood vessels. Unlike standard guidewires, which may be used for general vessel access or support, this device is engineered to facilitate the restoration of blood flow through severely obstructed vessels, making it ideal for cases involving chronic total occlusions or severe stenosis. Its specialized design helps navigate and penetrate hardened plaque or blockages.

  • Is the Schneider Magnum Peripheral Recanal Guidewire intended for reuse, or is it meant to be used only once?

    The device is explicitly labeled as single-use only. This means it should not be reused after a single procedure to ensure patient safety and maintain sterility. The regulatory submission does not indicate any reprocessing or sterilization protocols, reinforcing that each guidewire is intended for one-time use in a recanalization procedure.

  • How is the Schneider Magnum Peripheral Recanal Guidewire supplied, and what should clinicians consider when handling it?

    The guidewire is supplied in a non-sterile state, which means it must be sterilized by the clinical facility prior to use. Clinicians should follow their institution’s established sterilization protocols (e.g., ethylene oxide, autoclave, or gamma irradiation) to ensure safety before insertion. Additionally, since it is single-use, proper disposal after use is critical to prevent contamination or reuse.

  • What regulatory pathway was followed for FDA clearance of this guidewire, and what does that mean for clinicians?

    The Schneider Magnum Peripheral Recanal Guidewire received FDA 510(k) clearance under the Traditional review pathway, determined to be substantially equivalent to a legally marketed predicate device. This means the FDA evaluated it against an existing guidewire and confirmed it meets safety and effectiveness standards for peripheral vascular recanalization. Clinicians can rely on this clearance as evidence of the device’s regulatory compliance, though they should always follow their facility’s protocols for use and sterilization.